Finanical Statements
Ibnsina Pharma (ISPH.CA) Reports 6 Months Consolidated Results
Published at 12 August 2026 at 10:01Ibnsina PharmaRelated stock:Ibnsina Pharma stockAll Ibnsina Pharma disclosures
Disclosure summary
Company Name : Ibnsina Pharma
ISIN Code : EGS512O1C012
Currency : EGP
F/S Consolidated Period : From 01/01/2026 To 30/06/2026
Net Profit : 511,299,061
F/S Consolidated Period : From 01/01/2025 To 30/06/2025
Net Comparative Profit : 388,807,364
Audit Status : Reviewed
Comment : Taking into consideration minority rights
Source : Ibnsina Pharma
The Financial Statements in Arabic (3,694 KB)
The Financial Statements in English (3,261 KB)
ISIN Code : EGS512O1C012
Currency : EGP
F/S Consolidated Period : From 01/01/2026 To 30/06/2026
Net Profit : 511,299,061
F/S Consolidated Period : From 01/01/2025 To 30/06/2025
Net Comparative Profit : 388,807,364
Audit Status : Reviewed
Comment : Taking into consideration minority rights
Source : Ibnsina Pharma
The Financial Statements in Arabic (3,694 KB)
The Financial Statements in English (3,261 KB)